New blood marker could help doctors catch sepsis days sooner
NCT ID NCT07232784
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looked at whether measuring a protein called PSP in the blood can help doctors recognize sepsis earlier in ICU patients at high risk. Researchers enrolled 250 adults in China, taking daily blood samples until sepsis was diagnosed or ruled out. The goal was to see if PSP levels could predict sepsis up to three days before standard diagnosis, potentially leading to faster treatment and better outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Pancreatic stone protein (PSP) blood test
What this could lead to
If successful, this could give doctors a new tool to diagnose sepsis days earlier, allowing quicker treatment and potentially saving lives.
What could go wrong
This is an observational study, not a treatment trial. The test may not prove accurate enough in real-world settings, and results from 250 patients in China may not apply to all ICU populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shenzhen Third People's Hospital
Shenzhen, Guangdong, China
-
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
-
Zhuhai People's Hospital
Zhuhai, Guangdong, China